OEM Trademarks On Reprocessed Devices Do Not Mislead Hospitals - AMDR
This article was originally published in The Gray Sheet
Executive Summary
FDA should not require the removal of OEM trademarks and names from reprocessed devices because it would be inconsistent with the Kansas District Court's finding in U.S. Surgical Corp. v. Orris, Inc., according to the Association of Medical Device Reprocessors.
You may also be interested in...
CDRH Must Clarify Labeling Rules For Reprocessors - ADDM Citizen Petition
FDA should require reprocessors of single use devices to demonstrate prior to 510(k) clearance that a reused device will not bear an OEM trademark, the Association of Disposable Device Manufacturers asserts in a citizen petition to the agency.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.